ACADIA Pharmaceuticals Inc.
ACAD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $226,451 | -$61,286 | -$215,975 | -$167,870 |
| Dep. & Amort. | $15,883 | $5,552 | $2,026 | $3,344 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $67,049 | $66,421 | $68,201 | $63,615 |
| Change in WC | $4,155 | $18,133 | $37,991 | -$24,824 |
| Other Non-Cash | -$155,819 | -$12,118 | -$6,278 | $75 |
| Operating Cash Flow | $157,719 | $16,702 | -$114,035 | -$125,660 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$523 | -$40,050 | $0 | -$1,122 |
| Net Acquisitions | $0 | -$32,048 | $0 | $69,980 |
| Inv. Purchases | -$505,095 | -$369,985 | -$363,174 | -$492,797 |
| Inv. Sales/Matur. | $328,565 | $442,033 | $436,415 | $422,817 |
| Other Inv. Act. | $146,515 | $32,048 | $0 | -$69,980 |
| Investing Cash Flow | -$30,538 | $31,998 | $73,241 | -$71,102 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $6,845 | $25,129 | $8,199 | $18,162 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $6,845 | $25,129 | $8,199 | $18,162 |
| Forex Effect | -$94 | -$18 | $6 | $7 |
| Net Chg. in Cash | $133,932 | $73,811 | -$32,589 | -$178,593 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $194,427 | $114,846 | $153,205 | $331,798 |
| End Cash | $328,359 | $188,657 | $120,616 | $153,205 |
| Free Cash Flow | $157,196 | -$23,348 | -$114,035 | -$126,782 |